The platelet-derived growth factor (PDGF) signaling pathway plays important roles in development and progression of human cancers. In our study, we aimed to identify genetic variants of the PDGF pathway genes associated with pancreatic cancer (PC) risk in European populations using three published genome-wide association study datasets, which consisted of 9,381 cases and 7,719 controls. The expression quantitative trait loci (eQTL) analysis was also performed using data from the 1000 Genomes, TCGA and GTEx projects. As a result, we identified two potential susceptibility loci (rs5757573 and rs6001516) of PDGFB associated with PC risk [odds ratio (OR) 5 1.10, 95% confidence interval (CI) 5 1.05-1.16, and p 5 4.70 3 10 25 for the rs5757573 C allele and 1.21, 1.11-1.32, and 2.01 3 10 25 for the rs6001516 T allele]. Haplotype analysis revealed that the C-T haplotype carriers had a significantly increased risk of PC than those carrying the T-C haplotype (OR 5 1.23, 95% CI 5 1.12-1.34, p 55.00 3 10
Introduction
Pancreatic cancer (PC) is an aggressive malignant disease with a very poor prognosis. In the United States, PC is the fourth leading cause of cancer-related death, and approximately 53,070 people were diagnosed with PC and 41,780 died of this disease in 2016. 1 Although most cancers already have a much improved survival, advances in diagnosis and treatment for PCs have been slow, with a 5-year relative survival of only 8%. 1 This is mainly because PC is rarely detected at an early stage, and the etiology of PC is still not very clear. [2] [3] [4] As a consequence, there is an urgent need to construct a successful PC risk assessment model to identify people who are at high risk of PC, which can help advance our understanding of pancreatic carcinogenesis and disease progression and identify susceptible individuals for prevention and early detection to reduce the incidence and mortality of PC.
Age is a key risk factor for PC with the median age at diagnosis of PC of 72 years old. 5 Other environmental risk factors include male sex, diabetes, cigarette smoking and obesity. 6 While genetic basis for the majority of familial clustering of PC cases has yet to be explained clearly, several rare, moderately or highly penetrant mutations in some important PC genes have been identified, such as CFTR, BRCA2, PALB2, PRSS1, SPINK1, STK11 and DNA mis-match repair genes. 7 Some common genetic variants associated with PC risk have also been identified in recent genome-wide association studies (GWASs). [8] [9] [10] [11] [12] [13] [14] However, the overwhelming majority of the single-nucleotide polymorphisms (SNPs) identified by GWASs have been located in introns or intergenic regions, which do not have clear biological functions. SNPs in genes involved in specific biological pathways that may have important roles in the development and progression of PC need to be further explored. Several candidate gene/pathway-based association studies have been performed and identified multiple SNPs in genes associated with the risk of PC using the published GWAS dataset. [15] [16] [17] [18] [19] [20] In this study, we performed a candidate gene/pathway-based analysis using three PC GWAS datasets to identify potential susceptibility loci associated with PC risk. This strategy uses a limited number of SNPs based on their gene functions in a specific biological pathway, which significantly decreases dimension or multiple testing of genotyping data. The platelet-derived growth factor (PDGF) signaling pathway plays important roles in the development and progression of human cancers, because these genes regulate the processes of cell proliferation, apoptosis, migration, invasion and metastasis. [21] [22] [23] The mechanism of the PDGF signaling is to activate important cancer-associated signaling, such as the RAS/PI3K/ERK/AKT signaling, to stimulate DNA synthesis. 24, 25 Studies have demonstrated a link between the PDGF signaling pathway and PC. For example, a high PDGFR-B expression level correlates with a poor disease-free survival in PC patients, which has been proposed as a possible target for attenuating metastasis in the p53 mutant tumors. 26 While overexpression of PDGF-BB was found to be associated with a decreased PC growth by increasing tumor pericyte content, 27 a microarray-based gene expression profiling revealed that the PDGF signaling pathway was differently expressed in PC cell line SW1990, compared to two control cell lines, the HPDE6c7 and PANC-1 cells. 28 Based on these findings, we hypothesized that genetic variants of the PDGF signaling pathway genes are associated with risk of PC. To test this hypothesis, we conducted a comprehensive meta-analysis of genetic variants in genes of the PDGF signaling pathway using previously published GWAS datasets from the PanScan (the Pancreatic Cancer Cohort Consortium, and the Pancreatic Cancer Case-Control Consortium) and Pancreatic Cancer Case Control Association Study. We also explored potential correlations of the identified SNPs with mRNA expression levels of the genes.
Methods and Materials

Study subjects
The subjects in this case-control study were from two published GWASs: the PanScan study (phs000206.v5.p3) and the Pancreatic Cancer Case Control Association Study (dbGaP #:phs000648.v1.p1). The PanScan GWAS has three phases, including PanScan I, II and III (1,921 cases and 2,016 controls in PanScan I; 1754 cases, 1889 controls in PanScan II; 1538 cases, 0 controls in PanScan III). 8, 9, 13 Information Table S1 ). A written informed consent was obtained from study participants. All methods were performed in accordance with the relevant guidelines and regulations for each of participating institutions, and our study
What's new? There have been so many genetic variants that are likely to be associated with pancreatic cancer (PC) risk. In this analysis, the authors chose to focus on those variants in genes involved in the platelet-derived growth factor (PDGF)-signaling pathway, which has been implicated in many other cancers. Using datasets from genome-wide association studies, they identified two loci in the PDGF subunit B (PDGFB) gene that were correlated with increased PC risk and possibly also with decreased expression of PDGFB mRNA in PC tumors. These results suggest that genetic variants in PDGFB may thus play a role in PC susceptibility.
followed the study protocols approved by Duke University Health System Institutional Review Board.
Gene and SNP selection
The keyword "PDGF" was searched in Molecular Signatures Database (MSigDB) (http://www.broadinstitute.org/gsea/ msigdb/index.jsp), 31 and the resultant 129 related autosomal chromosomes genes involving in the PDGF signaling pathway from of BIOCARTA and REACTOME were included for further analysis (Supporting Information Table S2 ). For these GWAS datasets, genotyping was performed using Illumina HumanHap550v3.0, Human610_Quadv1_B, HumanOmniExpress-12v1.0 and HumanOmniExpressExome8v1. Genotyped SNPs located in these genes and their 6 500-kb flanking regions were extracted for imputation, which was conducted by IMPUTE2 software with the reference panel from the 1000 Genomes (phase 1 release V3). 32 Imputed
SNPs with an information score 0. Fig. 1; Supporting Information Fig. S1 ).
Statistical analysis
SNP association analysis was conducted first in a single locus analysis using a logistic regression model with adjustment for age, sex and the top principal components in the genotyping data. For each SNP, an odds ratio (OR) and its 95% confidence interval (95% CI) were estimated by unconditional logistic regression analysis of case/control groups with adjustment for age and principal components using PLINK. 33 With the inverse variance method, a meta-analysis was further used on the results of a log-additive model of 28,822 SNPs with Stata software (v12, State College, Texas). Cochran's Q statistics and I 2 were used to assess the heterogeneity (Q test p 0.10 or I 2 50%). 34 The analysis adopted fixed-effects models, if no heterogeneity; otherwise, random-effects models were used. The false discovery rate (FDR) approach with a cut-off value of 0.05 was applied to control for multiple testing and to reduce the probability of false-positive findings. 35 The association between each SNP and PC risk was assessed by an additive genetic model. In the combined risk genotype analysis, the multivariable stepwise logistic regression model was carried out to select the independent and significant SNPs, and the number of unfavorable genotypes (NUGs) of the significant SNPs was subsequently used to assess the classification performance of the model. All the individuals were divided into two groups: a low-risk Group (0 NUGs) and a high-risk Group (1-2 NUGs). Meanwhile, Haploview v4.2 was used to generate the Manhattan plots and linkage disequilibrium (LD) plots. LocusZoom (http://locuszoom.sph.umich.edu/locuszoom/) was used to construct the regional association plots using European populations from the 1000 Genomes Project. The correlations between SNPs and corresponding mRNA expression levels were calculated using a general linear regression model. Statistical analysis was carried out by R (version 3.3.1), SAS (version 9.4; SAS Institute, Cary, NC) and PLINK (version 1.07), if not specified otherwise. 41 The eQTL result of the online database genotype-tissue expression project (GTEx) was also taken into account in this analysis. 42 Comparisons of the targeted gene mRNA expression levels between tumor and adjacent normal tissues were performed in the Oncomine database (https://www. oncomine.org/). 43 
SNP-mRNA expression correlation analysis
Results
Single locus analysis
The workflow of the analysis is shown in Figure 1 . First, the associations between common SNPs (MAF 0.01) and PC risk for each of the three populations of European ancestry were estimated using unconditional logistic regression analysis. The SNP number in the PDGF pathway genes was 35,187, 36,542 and 31,389 for PanScan I, PanScan II/III and PanC4, respectively. Single locus analysis revealed that there were 1,969, 2,277 and 1,575 SNPs with a nominal p < 0.05, respectively (Supporting Information Fig. S2 ). Second, a total of 28,822 SNPs were included in a meta-analysis of the three populations, of which 1,794 SNPs were associated with PC risk at p < 0.05 in an additive model and 28 SNPs on BCAR1 and PDGFB passed multiple testing corrections with FDR < 0.05 ( Fig. 2a ; Table 1 ). Although the chromosome region (16q23.1) where BCAR1 is located has been previously reported by a GWAS, 13 the PDGFB gene located at 22q13.1 with seven SNPs (rs130651, rs6001516, rs35235663, rs56180415, rs6001512, rs71319025 and rs5757573) is a novel finding, for which we performed further in silico analysis. The results of the seven PDGFB SNPs in each of GWAS datasets and the final meta-analysis are summarized in Table 2 and Supporting Information Figure S3 . All SNPs showed a low heterogeneity among these three GWAS datasets (all Q-test p > 0.300 and I 2 < 20.0; Table 2 ).
LD and haplotype analysis
Further LD analysis revealed that of the seven PDGFB SNPs, five (rs6001516, rs35235663, rs56180415, rs6001512 and rs71319025) and another two SNPs (rs130651 and rs5757573) shared a high LD, respectively (r 2 0.80, Fig. 2c and 2d ). According to online functional prediction and LD analysis, therefore, we selected two proxy PDGFB SNPs (rs5757573 and rs6001516) for further analysis.
Haplotype (ht) analysis was used to evaluate the combined effect of the two proxy SNPs in PDGFB. There are four different haplotypes [ht1 (T-C), ht2 (C-C), ht3 (T-T) and ht4 (C-T)] at the rs5757573 and rs6001516 positions, but the frequency of ht3 was so low that we cannot provide a valid statistical interpretation. In addition, the results showed that haplotype ht4 including two risk alleles C and T was most (Table 3) .
Joint-effect analysis
We also assessed the joint effect of the two identified SNPs in the presence of age and sex in a multivariate stepwise logistic regression model, in which the data source was also taken into consideration in the pooled dataset of PanScan and PanC4 studies. As a result, the two independent SNPs remained significantly associated with PC risk (Supporting Information Table  S4 ). The results showed that rs5757573 T/C was significantly associated with PC risk in all the genetic models, so was rs6001516 C/T but not in the recessive genetic model. In an additive model, the associations between these two SNPs and cancer risk indeed had a linear trend as the frequency of the minor allele increased (trend test: p 5 0.0001 and p 5 3.3E-05, respectively, Supporting Information Table S5 ).
Consistent with previous results, individuals with genotypes of rs5757573 CT 1 CC and rs6001516 TC 1 TT had an increased risk of PC, compared to those with the wild-type genotype of each SNP in the pooled dataset (p 5 0.0004 and p 5 3.1E-05, respectively, Supporting Information Table S5) . Using a dominant model, we combined risk genotypes of rs5757573 CT 1 CC and rs6001516 TC 1 TT into a single variable as NUGs. The trend test indicated a significant association between increased NUGs and the risk of PC (p 5 5E-06, Supporting Information Table S6 ). Since the differences in age groups and gender are statistically significant in each dataset (Supporting Information Table S1 ) and advancing age is a
Cancer Epidemiology
Duan et al.
known risk factor for PC, we first performed subgroups (<60, 60-70, >70) analysis by age and found that the risk associated with NUG was more evident in 60-70 years age group (OR 5 1.19, 95% CI 5 1.07-1.33, p 5 0.002, Supporting Information Table S7 ). In the stratified analysis by sex, we found that the risk associated with NUG was more evident in males (OR 5 1.16, 95% CI 5 1.06-1.27, p 5 0.001, Supporting Information Table S7 ). However, no interaction and heterogeneity were observed between these strata (p > 0.05, Supporting Information Table S7 ).
Correlation analysis
Potential influence of the seven PDGFB SNPs on mRNA expression levels was preliminarily inferred through the online Table S3 ). Three SNPs (rs130651, rs6001516 and rs35235663) are located in the 5 0 upstream region of PDGFB, and the other four SNPs are located in the intronic regions, but all of these seven SNPs are located in the enhancer region of histone H3 mono methyl K4 (H3k4me1) that marks active/poised enhancers and in a DNase hypersensitive site representing open and active chromatins (Fig. 2b) . Moreover, we used the Genotype-Tissue Expression Project (GTEx) database (http://www.gtexportal.org/home/) to perform eQTL and showed that in the whole blood samples, the rs5757573 C allele was associated downregulated mRNA expression levels of PDGFB (p 5 5.8E-06) in an additive model (Supporting Information Fig. S4f ).
tools (Supporting Information
To substantiate the associations between the identified SNPs and PC risk, we also evaluated correlations between SNPs and mRNA expression levels of the corresponding genes in normal lymphoblastoid cell lines from 373 Europeans from the 1000 Genomes Project and in pancreatic tumor tissues from 127 Europeans in the TCGA-PAAD Project. However, we failed to impute the genotype of rs5757573 based on the current quality control in the population of the TCGA-PAAD Project. As tested by Student's t test or linear regression analysis of the logarithm transformed expression values (log2) using the data of lymphoblastoid cell lines in the 1000 Genomes Project, the rs5757573 C allele was significantly associated with lower levels of PDGFB mRNA 3 Fixed effect models were used when no heterogeneity was found between studies (Q test p > 0.10 and I 2 < 50.0%); otherwise, random effect models were used. 4 Meta-analysis of the three studies.
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expression (p 5 0.015 in an additive model [ Fig. 3a] and p 5 0.050 and 0.039 in dominant and recessive models, respectively [Supporting Information Figs. 4d and 4e] ) and the rs6001516 T allele had a marginal significant association with a decreased mRNA expression level of PDGFB in pancreatic tumor tissues from the TCGA (p 5 0.071, Fig. 3b) . However, the eQTL results for SNP rs6001516 were nonsignificant in lymphoblastoid cell lines in either genetic models (Supporting Information Figs. S4a, S4b and S4c) . In addition, we queried the eQTL results in the GTEx database and found that SNP rs5757573 also had a significant correlation with a decreased level of PDGFB mRNA expression in normal pancreatic tissues (p 5 0.037, Supporting Information Table S8 ), which is consistent with the results in whole blood cells from GTEx (Supporting Information Fig. S4f ) and lymphoblastoid cell lines from the 1000 Genomes project (Fig. 3a) .
Discussion
To investigate whether common germline variants in genes of the PDGF signaling pathway contribute to PC risk, we performed association analysis by using the data from three GWAS datasets: PanScan I, II/III from PanScan study and PanC4 from Pancreatic Cancer Case Control Association Study. Through meta-analysis, we identified two potential susceptibility loci for PC risk, which are located in PDGFB at 22q13.1. We further showed that both variants were independently or jointly associated with an increased PC risk, especially in the group with age of 60-70 years and males. Further eQTL analysis revealed that those two SNPs might influence the mRNA expression levels of PDGFB.
The PDGF signaling pathway plays an important role in the occurrence or/and development of PC. A series of studies have progressively revealed the complexity of the PDGF signaling network, among which the core factors are the PDGFs and their tyrosine kinase receptors (PDGFRs). 44 The PDGF isoforms are composed of four different polypeptide chains encoded by four different genes, namely PDGFA, PDGFB, PDGFC and PDGFD, corresponding to PDGF-A, PDGF-B, PDGF-C and PDGF-D. The four PDGF chains assemble into disulphide-bonded dimers via homo-or heterodimerization, and five different dimeric isoforms have been reported so far (PDGF-AA, PDGF-AB, PDGF-BB, PDGF-CC and PDGF-DD), which exert the effects by binding to, and activating, two protein tyrosine kinase receptors, alpha and beta. 45 In the previous studies on the effect of the PDGF signaling pathway in PC, the high PDGFRb expression levels correlate with a poor disease-free survival in PC patients with a gain-of-function activity of the mutant p53 that promotes invasion and metastasis. 26 However, one study investigated the mRNA expression in 13 human pancreatic tumors and found that although PDGF-A was expressed by nearly all of the specimens, 6 of 13 expressed low levels of PDGF-B. Logistic regression analysis was adjusted for sex, age and significant principal components in each study.
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tumor growth in human PC cells by increasing tumor pericyte content. 27 Using the online Oncomine database, we also found that the PDGFB expression levels in tumor tissue were lower than that in normal tissue in two studies from European populations. These reports and the Oncomine data suggest that PDGFB may act as a tumor suppressor in PC.
In our study, we found that the PDGFB rs5757573 C and rs6001516 T alleles were associated with an increased risk of 3 There are too few cases to prove statistically significant. 4 The dataset merged all the population. 
PC possibly by decreasing the mRNA expression levels of PDGFB in Europeans populations. It has been reported that SNP rs5757573 is correlated with mean arterial pressure in a study exploring the relationship between SNPs in inflammatory genes and vascular stiffness. 47 Other SNPs in PDGFB were also reported to be associated with primary biliary cirrhosis, inflammatory bowel disease and multiple myeloma. [48] [49] [50] These results indicated that genetic variants in PDGFB had effects on inflammatory reaction, specifically involved in chronic inflammatory diseases. Unresolved chronic inflammation is implicated in all stages of cancer development, and an inflammatory tumor microenvironment is considered a hallmark of cancer, including PC. 51 During pathophysiological processes (e.g., inflammation, fibrosis and tumor growth), pericytes can be activated by a combination of growth factors, especially PDGF-B, which can recruit pericytes into tumor blood vessels by the PDGF-B/ PDGFRb signaling. 52 Increasing pericytes would inhibit the growth of endothelial cells. 53 Taken together, genetic variants in PDGFB may lead to a decrease in pericytes by downregulating the expression of PDGF-B in the stage of precancerous inflammation to provide a feasible tumor microenvironment for PC cells, then finally leading to an increase in the risk of PC. However, additional mechanistic studies are required to investigate the biological mechanisms underlying the observed associations.
There are some limitations in our study. First, we had no access to family history and others clinical data in publically available datasets, which may have an impact on PC risk. Also, there was no information about any treatment or survival in the phenotype data, and thus we were unable to neither adjust for these covariates in the risk assessment model, nor assess their effects on clinical prognosis. Second, there was no control data in the PanScan III GWAS, which might have led the merged PanScan II/III GWAS datasets heterogeneous. Third, we were limited to evaluate whether a particular SNP had the biological function by only using the available online tools and eQTL analysis. More functional investigations are warranted to provide direct functional evidence to support our findings and to enable us consider which genetic variant in PDGFB may have played an important role in constructing the PC risk assessment model. Finally, except for SNPs nearby BCAR1 (a reported locus), no other SNPs could passed the Bonferroni correction for multiple testing (0.05/35187 SNPs 5 1.4 3 10
26
), even after we used the Meff method to calculate the number of independent SNPs (0.05/7061 independent SNP 5 7.08 3 10
). 54, 55 Although we applied FDR to control for false positive findings and in silico functional evidence has also been provided, further independent studies are required to replicate our findings.
In conclusion, our study analyzed the associations between genetic variants in PDGF signaling pathway genes and PC risk in European populations. We identified two SNPs in PDGFB (rs5757573 T > C and rs6001516 C > T) that were associated with an increased risk of PC. Our results suggested that two identified SNPs in PDGFB may play a role in susceptibility to PC. Further population and functional validations of our findings are warranted.
